secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2024-12-20T23:59:59+00:00
Accession:  0001213900-24-111279
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud

Envoy Medical enters Conversion and Waiver Agreement with sponsor, modifying preferred stock terms and converting shares
--------------------------------------------------------------------------------

- Sponsor Anzu waives $3,733,333 in accrued dividends on Series A Preferred Stock.
- Envoy waives vesting restrictions on 1,000,000 restricted shares held by Anzu.
- Conversion price on Preferred Stock temporarily reduced from $11.50 to $3.63 per share through Jan 20, 2025.
- Anzu converts 373,333 Preferred Stock shares into 1,028,986 shares of common stock.
- Agreement executed December 20, 2024, closing same day.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000121390024111279/0001213900-24-111279-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000121390024111279/ea0225604-8k_envoy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-111279

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer